Skip to content
logo_IFAPP_crop
  • About
    • Mission & Objectives
    • Definition of Pharmaceutical Medicine
    • PharmaTrain Syllabus
    • Governance
      • The Board of Officers
      • The House of Delegates
      • The General Assembly
    • Constitution
    • History
      • Council of Past Presidents
  • News
    • News & Posts
    • IFAPP World Newsletter Past Editions
  • IFAPP TODAY
  • Working Groups
    • Communication
    • Education and Certification
    • Ethics
    • External Affairs
    • Young Professionals
  • Collaborations & Partners
  • Events
  • Members and Individual Affiliates
  • Publications
  • Course Marketplace

EMA: Orphan Medicines Figures

By Anna Jurczynska | March 7, 2018

Orphan Medicines Figures 2000- 2017

Orphan Medicines – Product Development Scientific Support

 

To view the full report visit https://www.ema.europa.eu/docs/en_GB/document_library/Report/2018/02/WC500244421.pdfhttps://www.ema.europa.eu/docs/en_GB/document_library/Report/2018/02/WC500244422.pdf

This article was originally posted on the EMA website. 

Posted in Recent News
← EMA: Highlight report of the 2nd industry stakeholder platform on research and development supportEMA: How to better apply the paediatric legislation to boost development of medicines for children →

Recent Posts

  • Introduction to the new EU Clinical Trials Regulation
  • IFAPP TODAY | JANUARY 2023 | NUMBER 30
  • ICPM 2022: Scientists call for cooperative participation of all partners & patients in R&D of new drugs
  • Innovative Options for Course Providers
  • IFAPP TODAY | NOVEMBER/DECEMBER 2022 | NUMBER 29

Categories

  • I am IFAPP
  • Recent News

IFAPP secretariat

Leidsestraatweg 41-D

3443 BP WOERDEN

THE NETHERLANDS

Chamber of Commerce: 30224375

Phone: +31 6 2291 1039

E-mail: secretariat@ifapp.org

Privacy Policy

Cookie Policy

logo_icon

Created By: MDM Creative | ©2019